721 related articles for article (PubMed ID: 14530334)
21. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
22. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.
Melief CJ; Van Der Burg SH; Toes RE; Ossendorp F; Offringa R
Immunol Rev; 2002 Oct; 188():177-82. PubMed ID: 12445291
[TBL] [Abstract][Full Text] [Related]
23. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
24. CD40-targeted recombinant adenovirus significantly enhances the efficacy of antitumor vaccines based on dendritic cells and B cells.
Kim YS; Kim YJ; Lee JM; Han SH; Ko HJ; Park HJ; Pereboev A; Nguyen HH; Kang CY
Hum Gene Ther; 2010 Dec; 21(12):1697-706. PubMed ID: 20604681
[TBL] [Abstract][Full Text] [Related]
25. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86.
Agadjanyan MG; Chattergoon MA; Holterman MJ; Monzavi-Karbassi B; Kim JJ; Dentchev T; Wilson D; Ayyavoo V; Montaner LJ; Kieber-Emmons T; Sekaly RP; Weiner DB
J Immunol; 2003 Oct; 171(8):4311-9. PubMed ID: 14530356
[TBL] [Abstract][Full Text] [Related]
26. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
Dell K; Klein C; Gissmann L
Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
[TBL] [Abstract][Full Text] [Related]
27. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process.
Marovich MA; McDowell MA; Thomas EK; Nutman TB
J Immunol; 2000 Jun; 164(11):5858-65. PubMed ID: 10820265
[TBL] [Abstract][Full Text] [Related]
28. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
Jaiswal AI; Dubey C; Swain SL; Croft M
Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B.
Lee JI; Ganster RW; Geller DA; Burckart GJ; Thomson AW; Lu L
Transplantation; 1999 Nov; 68(9):1255-63. PubMed ID: 10573060
[TBL] [Abstract][Full Text] [Related]
30. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
[TBL] [Abstract][Full Text] [Related]
31. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy.
Seko Y; Takahashi N; Ishiyama S; Nishikawa T; Kasajima T; Hiroe M; Suzuki S; Ishiwata S; Kawai S; Azuma M; Yagita H; Okumura K; Yazaki Y
Circulation; 1998 Feb; 97(7):637-9. PubMed ID: 9495297
[TBL] [Abstract][Full Text] [Related]
32. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.
Fujii S; Liu K; Smith C; Bonito AJ; Steinman RM
J Exp Med; 2004 Jun; 199(12):1607-18. PubMed ID: 15197224
[TBL] [Abstract][Full Text] [Related]
33. TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.
Padigel UM; Kim N; Choi Y; Farrell JP
J Immunol; 2003 Nov; 171(10):5437-41. PubMed ID: 14607948
[TBL] [Abstract][Full Text] [Related]
34. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
35. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
[TBL] [Abstract][Full Text] [Related]
36. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors.
de Gruijl TD; Luykx-de Bakker SA; Tillman BW; van den Eertwegh AJ; Buter J; Lougheed SM; van der Bij GJ; Safer AM; Haisma HJ; Curiel DT; Scheper RJ; Pinedo HM; Gerritsen WR
J Immunol; 2002 Nov; 169(9):5322-31. PubMed ID: 12391253
[TBL] [Abstract][Full Text] [Related]
37. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.
Fiumara P; Snell V; Li Y; Mukhopadhyay A; Younes M; Gillenwater AM; Cabanillas F; Aggarwal BB; Younes A
Blood; 2001 Nov; 98(9):2784-90. PubMed ID: 11675352
[TBL] [Abstract][Full Text] [Related]
38. Histamine induces CD86 expression and chemokine production by human immature dendritic cells.
Caron G; Delneste Y; Roelandts E; Duez C; Herbault N; Magistrelli G; Bonnefoy JY; Pestel J; Jeannin P
J Immunol; 2001 May; 166(10):6000-6. PubMed ID: 11342615
[TBL] [Abstract][Full Text] [Related]
39. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines.
Yoshimura S; Bondeson J; Foxwell BM; Brennan FM; Feldmann M
Int Immunol; 2001 May; 13(5):675-83. PubMed ID: 11312255
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
